108 related articles for article (PubMed ID: 3962565)
1. Serum melatonin is not affected by glucocorticoid replacement in congenital adrenal hyperplasia.
Waldhauser F; Frisch H; Krautgasser-Gasparotti A; Schober E; Bieglmayer C
Acta Endocrinol (Copenh); 1986 Mar; 111(3):355-9. PubMed ID: 3962565
[TBL] [Abstract][Full Text] [Related]
2. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP
J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
[TBL] [Abstract][Full Text] [Related]
3. Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.
Sólyom J
Arch Dis Child; 1984 Aug; 59(8):743-7. PubMed ID: 6541026
[TBL] [Abstract][Full Text] [Related]
4. 17OH-progesterone response to acute dexamethasone administration in congenital adrenal hyperplasia.
Shen SX; Young MC; Hinohosa-Sandoval M; Hughes IA
Horm Res; 1989; 32(4):136-41. PubMed ID: 2625323
[TBL] [Abstract][Full Text] [Related]
5. Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements.
Hughes IA; Read GF
Horm Res; 1984; 19(2):77-85. PubMed ID: 6538545
[TBL] [Abstract][Full Text] [Related]
6. A comparison of three glucocorticoid suppressive regimes in adults with congenital adrenal hyperplasia.
Horrocks PM; London DR
Clin Endocrinol (Oxf); 1982 Dec; 17(6):547-56. PubMed ID: 6299623
[TBL] [Abstract][Full Text] [Related]
7. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
[TBL] [Abstract][Full Text] [Related]
8. Age of appearance of circadian rhythm in blood 17-hydroxyprogesterone in 21-hydroxylase deficiency.
Sólyom J
Acta Physiol Hung; 1991; 78(2):107-10. PubMed ID: 1808976
[TBL] [Abstract][Full Text] [Related]
9. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid receptors in patients with congenital adrenal hyperplasia.
Saka N; Güven M; Baş F; Darendeliler F; Bundak R; Günöz H; Sultuybek G
J Pediatr Endocrinol Metab; 2000; 13(8):1101-7. PubMed ID: 11085188
[TBL] [Abstract][Full Text] [Related]
11. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L
J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
[TBL] [Abstract][Full Text] [Related]
12. [Adrenal hyperplasia of late onset: optimization of therapy by measuring the circadian variation of serum 17-OH-progesterone].
Contreras P; Rojas A; Vega I
Rev Med Chil; 1989 Jun; 116(6):552-7. PubMed ID: 2749040
[TBL] [Abstract][Full Text] [Related]
13. Pituitary-adrenal responses to corticotropin-releasing hormone in different degrees of adrenal 21-hydroxylase deficiency.
Moreira AC; Elias LL
J Clin Endocrinol Metab; 1992 Jan; 74(1):198-203. PubMed ID: 1309366
[TBL] [Abstract][Full Text] [Related]
14. Blood-spot 17-hydroxyprogesterone daily profiles in infants with congenital adrenal hyperplasia.
Sólyom J; Hosszu E; Gács G
Exp Clin Endocrinol; 1990 Sep; 96(1):52-6. PubMed ID: 2279525
[TBL] [Abstract][Full Text] [Related]
15. Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia.
Dubinski I; Bechtold Dalla-Pozza S; Bidlingmaier M; Reisch N; Schmidt H
J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1543-1548. PubMed ID: 34523293
[TBL] [Abstract][Full Text] [Related]
16. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
[TBL] [Abstract][Full Text] [Related]
17. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
Sulcová J; Lisá L; Dvorák P; Hampl R; Stárka L
Cesk Pediatr; 1990 Jun; 45(6):353-6. PubMed ID: 2289256
[TBL] [Abstract][Full Text] [Related]
18. Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasia.
Ross RJ; Rostami-Hodjegan A
Horm Res; 2005; 64 Suppl 2():67-70. PubMed ID: 16286775
[TBL] [Abstract][Full Text] [Related]
19. Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.
Linder B; Feuillan P; Chrousos GP
J Clin Endocrinol Metab; 1989 Jul; 69(1):191-5. PubMed ID: 2543690
[TBL] [Abstract][Full Text] [Related]
20. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
